Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30–60 μm: Results from a Single-Centre Prospective Phase II Trial
Malagari, K., Moschouris, H., Kiakidis, Th., Harward, S., Kelekis, A., Vrakas, S., Koundouras, D., Filipiadis, D., Glantzounis, G., Emmanouil, E., Chatziioannou, A., Vergadis, V., Elefsiniotis, I., KoLanguage:
english
Journal:
CardioVascular and Interventional Radiology
DOI:
10.1007/s00270-019-02260-3
Date:
July, 2019
File:
PDF, 941 KB
english, 2019